Does Cigna Cover ADHD Treatment in Hawaii? A 2026 Guide

Last updated: July 17, 2026

Key facts for Cigna members in Hawaii (2026): Cigna uses Express Scripts (ESI) as its pharmacy benefit manager in Hawaii. Under Cigna’s prior authorization policy IP0477 (effective May 15, 2026), all ADHD stimulant medications require prior authorization — including generic Tier 1–2 options. Non-stimulant ADHD medications are non-scheduled and are not subject to Hawaii’s electronic prescribing law (HRS § 329-38.5). Hawaii’s parity law (Haw. Rev. Stat. § 431M-1 et seq.) requires that mental health benefits — including ADHD — be covered comparably to medical benefits. If you are a Cigna member in Hawaii looking for ADHD care, Klarity Health connects you with licensed providers who accept Cigna and are familiar with ESI’s prior authorization requirements.

Ready to get started with ADHD treatment?
Check if your Cigna plan may cover ADHD treatment through Klarity Health →

Cigna ADHD Coverage in Hawaii: What Members Need to Know

Attention-deficit/hyperactivity disorder (ADHD) is one of the most commonly diagnosed conditions in the United States, affecting both children and adults. For Cigna members in Hawaii, coverage for ADHD diagnosis, therapy, and medication is available — but navigating formulary tiers, prior authorization requirements, and state-specific rules takes preparation.

This guide covers the Express Scripts formulary for ADHD medications, Cigna’s May 2026 PA policy change (IP0477), Hawaii’s electronic prescribing law, and the state parity protections that apply to your plan.

Does Cigna Cover ADHD Diagnosis and Therapy in Hawaii?

Cigna’s commercial plans in Hawaii typically cover ADHD-related services including:

• Psychiatric evaluation and ADHD diagnostic assessment
• Psychological testing (neuropsychological and educational)
• Individual therapy and behavioral therapy (CBT, behavioral management)
• Medication management appointments
• Intensive outpatient programs (IOP) for co-occurring conditions
• Telehealth ADHD consultations

Coverage details — including in-network requirements, deductibles, and copays — vary by specific plan. Cigna members should call the member services number on their insurance card (1-800-244-6224) or log into myCigna.com to verify their specific benefits before scheduling care.

Cigna ADHD Medication Formulary (Express Scripts, 2026)

Cigna uses Express Scripts (ESI) as its pharmacy benefit manager for most commercial plans in Hawaii. The table below reflects the standard ESI commercial formulary for ADHD medications as of 2026. Coverage and tier placement may vary by specific Cigna plan. Always confirm your plan’s formulary at Express Scripts (1-800-835-3784) or myCigna.com before filling a prescription.

Cigna IP0477: The 2026 Prior Authorization Policy Change

Cigna implemented prior authorization policy IP0477 effective May 15, 2026. Under this policy, all ADHD stimulant medications require prior authorization — including generic formulations that were previously available at Tier 1–2 without PA.

This is a significant change for Hawaii Cigna members who may have previously filled generic Adderall, methylphenidate, or dextroamphetamine at the pharmacy counter without a PA on file. Under IP0477:

• All Schedule II stimulants (regardless of generic vs. brand) require prior authorization
• PA is submitted through Cigna’s provider portal (Availity at availity.com or cigna.com/providers)
• Supporting documentation typically includes: confirmed ADHD diagnosis, clinical history, prescriber information
• Brand stimulants additionally require step therapy documentation showing an adequate trial of a generic stimulant
• Standard PA turnaround: 2–3 business days; urgent requests: 24–72 hours

Providers submitting PA requests for Cigna Hawaii members should use Availity or the Cigna provider portal. Members with questions about a PA decision may call Cigna member services at 1-800-244-6224 or Express Scripts at 1-800-835-3784.

Hawaii Electronic Prescribing of Controlled Substances (EPCS) and ADHD Medications

Hawaii’s electronic prescribing law (Haw. Rev. Stat. § 329-38.5) requires that prescriptions for Schedule II controlled substances be transmitted electronically in most circumstances. Understanding which ADHD medications fall under this requirement — and which do not — helps patients and providers prepare.

Stimulant ADHD Medications — EPCS Required

The following ADHD medications are Schedule II controlled substances and are subject to HRS § 329-38.5:

• Amphetamine salts (Adderall, Adderall XR, and generics)
• Dextroamphetamine (Dexedrine and generics)
• Lisdexamfetamine (Vyvanse and generic)
• Methylphenidate (Ritalin, Concerta, and generics)
• Methamphetamine (Desoxyn — rarely used for ADHD)

Providers prescribing these medications in Hawaii must use an approved EPCS system unless a statutory exception applies (such as a technical failure or prescriber exemption). Patients should verify that their prescribing provider is EPCS-compliant before their appointment to avoid delays at the pharmacy.

Non-Stimulant ADHD Medications — EPCS Inapplicable

Non-stimulant ADHD medications are not controlled substances and are entirely exempt from HRS § 329-38.5:

• Atomoxetine (Strattera and generic) — non-scheduled
• Guanfacine ER (Intuniv and generic) — non-scheduled
• Clonidine ER (Kapvay and generic) — non-scheduled
• Viloxazine (Qelbree) — non-scheduled

These medications may be prescribed using any transmission method (electronic, paper, or telephone) and are not subject to EPCS requirements under Hawaii law. This distinction is meaningful for patients who prefer non-stimulant treatment options or who work with providers not yet enrolled in an EPCS system.

Note for West Virginia comparison: West Virginia’s EPCS law (W. Va. Code § 60A-4-403a) covers all controlled substances, including Schedule IV and V. Hawaii’s HRS § 329-38.5 covers only Schedule II. This distinction matters for patients who have lived in or received care in multiple states.

Hawaii Mental Health Parity Law and ADHD Coverage

Hawaii’s mental health and substance use disorder parity law (Haw. Rev. Stat. § 431M-1 et seq.) requires that health plans offering mental health or substance use disorder benefits do so at parity with medical and surgical benefits. ADHD is classified as a mental health condition under this framework.

Under § 431M-1 et seq., Cigna’s commercial plans in Hawaii may not:

• Impose more restrictive prior authorization requirements for ADHD treatment than for comparable medical conditions
• Apply lower day or visit limits to ADHD therapy or medication management
• Charge higher cost-sharing for mental health services than for medical/surgical services

The parity law applies to fully insured commercial plans regulated by the Hawaii Insurance Division. Self-funded employer plans are governed by MHPAEA federally (via ERISA) rather than the state statute, though the substantive parity requirements are similar. Members whose claims are denied in a manner that may violate parity protections may file a complaint with the Hawaii Insurance Division at 1-808-586-2790 or insurance.hawaii.gov.

Hawaii Prepaid Health Care Act and ADHD Benefits

Hawaii is the only state with a prepaid health care law that requires employers to provide health insurance to employees working 20 or more hours per week (Haw. Rev. Stat. § 393). The Hawaii Prepaid Health Care Act mandates certain minimum benefit standards and requires employer contributions to employee health coverage.

Key points for employees covered under the Prepaid Health Care Act:

• Employers must offer qualifying health coverage to eligible employees (≥20 hours/week)
• Mental health benefits — including ADHD — are subject to state parity requirements (§ 431M-1 et seq.) within Prepaid Health Care Act plans
• Self-employed individuals and certain categories of workers may have different coverage requirements
• For questions about the Prepaid Health Care Act, contact the Hawaii Department of Labor and Industrial Relations (DLIR) at 1-808-586-8777

What ADHD Services May Cigna Cover in Hawaii?

Cigna commercial plans in Hawaii typically may cover a range of ADHD-related services, subject to plan design, deductibles, and in-network requirements:

• Diagnostic evaluation: Psychiatric assessment, clinical interviews, behavioral rating scales
• Psychological testing: Neuropsychological and psychoeducational testing (may require prior authorization)
• Therapy: Individual therapy (CBT, behavioral interventions), family therapy, parent training
• Medication management: Prescribing appointments, follow-up visits, titration monitoring
• Telehealth: Virtual ADHD assessment and medication management appointments
• Intensive outpatient programs (IOP): For co-occurring anxiety, depression, or substance use

Coverage specifics — including deductible requirements, in-network providers, and prior authorization thresholds — vary by plan. Always call the member services number on your Cigna card or visit myCigna.com to verify your individual benefits.

How to Verify Your Cigna ADHD Coverage in Hawaii

1. Call Cigna member services at 1-800-244-6224 and ask specifically about your behavioral health benefits, ADHD diagnostic codes (F90.x), and whether your plan requires referrals or prior authorization for ADHD evaluation
2. Check your formulary at myCigna.com or by calling Express Scripts at 1-800-835-3784 — confirm the tier placement and PA status of any specific ADHD medication under IP0477
3. Verify your provider’s network status — confirm that your ADHD provider (psychiatrist, APRN, or telehealth service) is in-network with Cigna in Hawaii
4. Confirm EPCS compliance if your provider plans to prescribe Schedule II stimulants — ask whether they are enrolled in an EPCS system as required by HRS § 329-38.5
5. Review your Explanation of Benefits (EOB) after your first appointment to confirm cost-sharing matches your plan documents

Getting ADHD Care Through Klarity Health with Cigna

Klarity Health connects Hawaii residents with licensed psychiatric providers who offer telehealth ADHD evaluations and ongoing medication management. Our network includes 2,000+ licensed providers — including prescribers who are familiar with Cigna/ESI prior authorization requirements and Hawaii’s EPCS compliance obligations for Schedule II stimulants.

Klarity providers use EPCS-compliant systems for Schedule II stimulant prescriptions, ensuring your prescription can be transmitted electronically as required by HRS § 329-38.5. Our team can assist with PA documentation needs for Cigna’s IP0477 policy.

See if your Cigna plan may cover ADHD treatment through Klarity Health →

Frequently Asked Questions

Does Cigna cover Adderall in Hawaii?

Generic amphetamine salts (the generic form of Adderall) are typically on the ESI formulary at Tier 1–2, but as of May 15, 2026, all stimulants require prior authorization under Cigna’s IP0477 policy. Your provider will need to submit a PA request through Availity or cigna.com/providers. If approved, your copay will reflect the Tier 1–2 cost-sharing. Contact Express Scripts at 1-800-835-3784 to confirm tier placement for your specific plan.

Does Cigna cover Vyvanse in Hawaii?

Vyvanse (brand lisdexamfetamine) is typically Tier 3–4 on the ESI formulary and requires prior authorization including step therapy documentation. Generic lisdexamfetamine is now available and is typically Tier 2–3 — verify the specific tier with your plan. Generic versions may require less documentation than brand Vyvanse. Both brand and generic require PA under IP0477. Call ESI at 1-800-835-3784 to confirm.

Do I need a referral from my primary care doctor to see an ADHD specialist with Cigna in Hawaii?

Whether a referral is required depends on your specific Cigna plan type. HMO plans typically require a referral from a primary care provider (PCP) to see a psychiatrist or specialist. PPO plans typically allow direct access to in-network specialists without a referral. Log into myCigna.com or call 1-800-244-6224 to confirm your plan’s referral requirements.

Does Hawaii’s EPCS law apply to non-stimulant ADHD medications like Strattera?

No. HRS § 329-38.5 applies only to Schedule II controlled substances. Non-stimulant ADHD medications — including atomoxetine (Strattera), guanfacine ER, clonidine ER, and viloxazine (Qelbree) — are not scheduled controlled substances and are entirely exempt from Hawaii’s electronic prescribing requirement. These medications may be prescribed using any method.

What happens if Cigna denies my ADHD medication PA request?

If your prior authorization is denied, you have the right to appeal. Steps include: (1) request a written denial letter from Cigna explaining the reason; (2) ask your provider to submit a peer-to-peer review with Cigna’s medical director; (3) file a formal internal appeal with Cigna within the timeframe noted in the denial letter; (4) if the internal appeal is unsuccessful, request an external independent medical review. If you believe the denial violates Hawaii’s parity law (§ 431M-1 et seq.), you may file a complaint with the Hawaii Insurance Division at 1-808-586-2790.

Does the Hawaii Prepaid Health Care Act guarantee ADHD coverage?

The Hawaii Prepaid Health Care Act (HRS § 393) requires employers to provide qualifying health coverage to employees working 20 or more hours per week, and those plans are subject to Hawaii’s mental health parity law (§ 431M-1 et seq.). However, the specific scope of ADHD benefits — including which medications and therapy sessions are covered — is determined by the plan design. The Act mandates employer-sponsored coverage access, not specific ADHD benefit levels beyond parity requirements. For questions, contact the Hawaii DLIR at 1-808-586-8777.

Contact Information

• Cigna member services: 1-800-244-6224 | myCigna.com
• Express Scripts (ESI): 1-800-835-3784 | express-scripts.com
• Cigna / Availity provider portal (PA submissions): availity.com | cigna.com/providers
• Hawaii Insurance Division: 1-808-586-2790 | insurance.hawaii.gov
• Hawaii DLIR (Prepaid Health Care Act): 1-808-586-8777
• SAMHSA National Helpline: 1-800-662-4357 (free, confidential mental health/SUD referrals)
• 988 Suicide and Crisis Lifeline: Call or text 988
• Klarity Health: helloklarity.com/service/adhd-treatment

Disclaimer: This page is for informational purposes only and does not constitute legal, medical, or insurance advice. Coverage details, formulary tiers, and prior authorization requirements vary by plan and are subject to change. The information above reflects publicly available sources as of July 2026. Always verify your specific benefits directly with Cigna (1-800-244-6224) and Express Scripts (1-800-835-3784) before scheduling care or filling a prescription. Self-funded employer plans may be subject to different rules under ERISA. Klarity Health is an independent telehealth platform and is not affiliated with Cigna or Express Scripts.